R2 $86 Mil. Offering Would Fund LungCheck CAD Software Development
This article was originally published in The Gray Sheet
Executive Summary
R2 Technologies' proposed initial public offering will fund development of the LungCheck computer-aided detection (CAD) system for screening abnormalities in chest computerized tomography (CT) scans, and shore up its current mammography CAD business